2026 ACMG
Annual Clinical
Genetics Meeting

Streamlining Carrier Screening Insights, Even for the Most Challenging Genes

Asuragen is leveraging its gold-standard PCR chemistry with Oxford Nanopore’s long-read DNA sequencing capabilities to develop the first sequencing system to resolve the most challenging, high-prevalence carrier genes in a single, unified workstream that today requires multiple other methods.

The AmplideX^® suite of products helps solve unmet testing needs in inherited genetic disorders by leveraging expertise in reliable amplification of GC-rich and high homology target sequences like FMR1. Asuragen’s AmplideX technology lends accuracy, sensitivity, and specificity to analysis of other hard-to-amplify genetic targets and is designed for seamless integration with established laboratory equipment, ensuring accessibility and ease of adoption.

Assays and included data reporting solutions are designed with labs in mind to optimize efficiency, reduce hands-on time, and minimize costs. Driven by the pursuit of unraveling the complexities of inherited genetic disorders, Asuragen’s AmplideX technology empowers you to provide better answers.